🔴 Neuroone Medical Technologies is trading 11.55% down in pre-market; no clear catalyst identified

Neuroone Medical Technologies is trading at $0.81, down 11.55% in pre-market on October 26, with no clear company-specific catalyst identified.

• The latest identified company announcement, dated October 22, described a first pharmaceutical-industry purchase order for its StereoCED platform; the research program is expected to begin early next year. That earlier news does not clearly explain the decline.
• Supplied market indicators are mixed, not a strong same-direction move. Pre-market volume or trading activity data was not provided, so the move’s activity level cannot be assessed.